Medically prescribed products containing THC have shown value and safety in the management of a number of important clinical conditions, including debilitating chronic pain. Emyria who have seen over 3500 patients upholds evidence-based investigation and pharmacovigilance. Many patients are unfairly prohibited from access to these products by out-of-date driving legislation and testing that is not evidence-based. We need to Drive Change to prohibit driving with impairment, not driving with improvement.

Dr Alistair Vickery

Medical Director: Emerald Clinics
Recent posts

Working and driving rights are human rights

If your prescribed medicine prevents you from driving and working, what does that mean for your human rights? The UK’s Cannabis Industry Council released a report this week into workplace issues for medicinal cannabis patients who are regarded as disabled under UK work, health and safety laws. Despite its specificity, it is a worthwhile read […]

Read more

Precarious working lives and longest days

Drive Change’s David Heilpern got some great soundbites in last Saturday morning and ABC News ran them on the hour, every hour, all day. This is the benefit of having elected reps in Victoria, WA and NSW bringing on topical parliamentary debates on cannabis law reform. Journalists will ring us to discuss this News, interview […]

Read more